Kawase, Kazumi, Kazuhiko Yoshida, Keigo Hara, Suguru Hidaka, and Hiroshi Takeyama. “Efficacy and Safety of Neoadjuvant Chemotherapy With Dose De-Escalation Tri-Weekly Nanoparticle Albumin-Bound Paclitaxel and FEC for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer”. Clinical Medicine Insights 4, no. 2 (June 9, 2023): 378–386. Accessed November 20, 2024. http://medicineinsights.info/index.php/cmi/article/view/179.